Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Container Closure Integrity Testing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Container Closure Integrity Testing – V 2.0

Standard Operating Procedure for Container Closure Integrity Testing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/070/2025
Supersedes SOP/SIM/070/2022
Page No. Page 1 of 13
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP outlines the procedure for performing Container Closure Integrity Testing (CCIT) on sterile injectable pharmaceutical products to verify the integrity of packaging systems and ensure product sterility throughout its shelf life.

2. Scope

This procedure applies to all finished injectable products packaged in ampoules, vials, or prefilled syringes at the

sterile manufacturing facility.

3. Responsibilities

  • QC Analyst: Conducts CCIT and records the results.
  • QC Reviewer: Reviews data for compliance and correctness.
  • QA Officer: Verifies integrity test results prior to batch release.

4. Accountability

The Head of Quality Control is accountable for ensuring the integrity of the container closure system through validated CCIT methods.

See also  Sterile Injectable Manufacturing: SOP for Investigations of Complaints Related to Injectable Products - V 2.0

5. Procedure

5.1 Sampling

  1. Collect samples from each batch as per sampling plan (refer Annexure-1: Sample Log).
  2. Include samples from the beginning, middle, and end of the filling process.

5.2 Test Methods

  1. Use any of the following validated techniques based on product and packaging type:
    • Vacuum Decay Method
    • Helium Leak Detection
    • High Voltage Leak Detection (HVLD)
    • Dye Ingress Test
  2. Ensure all equipment used is calibrated and validated before use (see Annexure-2: Equipment Calibration Log).

5.3 Execution of CCIT

  1. Inspect each sample using the chosen method according to the validated SOPs.
  2. For HVLD:
    • Connect the syringe/vial to the HVLD system.
    • Apply voltage and record any current leakage.
    • A value above set threshold indicates failure.
  3. For dye ingress:
    • Submerge samples in 0.1% methylene blue solution and apply vacuum.
    • Inspect for dye penetration after specified hold time.
  4. Document all observations in Annexure-3: CCIT Results Sheet.
See also  Manufacturing: SOP for Temperature and Humidity Monitoring during Production - V 2.0

5.4 Acceptance Criteria

  1. All samples must pass CCIT without leak detection, dye ingress, or voltage current beyond limit.
  2. If any sample fails, follow deviation and batch investigation procedures.

5.5 Handling Failures

  1. Isolate failed sample and inform QA.
  2. Initiate root cause investigation and evaluate impact on batch disposition.
  3. Record investigation in Annexure-4: CCIT Failure Report.

6. Abbreviations

  • CCIT: Container Closure Integrity Testing
  • HVLD: High Voltage Leak Detection
  • QA: Quality Assurance
  • QC: Quality Control
  • SOP: Standard Operating Procedure

7. Documents

  1. Sample Log – Annexure-1
  2. Equipment Calibration Log – Annexure-2
  3. CCIT Results Sheet – Annexure-3
  4. CCIT Failure Report – Annexure-4

8. References

  • USP <1207> Container Closure Integrity Testing
  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 996 – Annex 6

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation QC Analyst QA Executive Head QA
Department Quality Control Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Sample Log

Date Product Batch No. Sampled By Remarks
17/06/2025 Diclofenac Injection DFC-0625-B Anil Sharma Start, mid, end samples

Annexure-2: Equipment Calibration Log

Equipment ID Type Calibration Date Calibrated By Remarks
HVLD-01 HV Leak Detector 01/06/2025 Rajesh Kumar Calibrated

Annexure-3: CCIT Results Sheet

Sample ID Method Result Tested By Remarks
DFC-0625-B-01 HVLD Pass Sunita Reddy —

Annexure-4: CCIT Failure Report

Sample ID Failed Method Description Action Taken Reported By
DFC-0625-B-07 Dye Ingress Blue dye detected Sample quarantined Vinay Pawar

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial issue New SOP QA Head
18/06/2025 2.0 Added HVLD protocol and updated annexures Annual Review QA Head
See also  Sterile Injectable Manufacturing: SOP for Subcutaneous Injection Batch Manufacturing - V 2.0
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Elixir Department: SOP for Addition of Volatile Solvents Under Fume Hood – V 2.0
Next Post: Gel Manufacturing: SOP for Visual Inspection of Packed Gel Units – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version